Key result
Once-daily amlodipine/atorvastatin combination therapy with home BP monitoring achieved significant declines in BP, total cholesterol, and LDL in indigent African Americans.
Why the study?
Does once-daily amlodipine/atorvastatin combination therapy with home BP monitoring improve blood pressure and lipid control in indigent African Americans with resistant hypertension and dyslipidemia?
RCT
Randomly assigned
Does once-daily amlodipine/atorvastatin combination therapy with home BP monitoring improve blood pressure and lipid control in indigent African Americans with resistant hypertension and dyslipidemia?
Answers are grounded in this paper and cite their sources.
Once-daily amlodipine/atorvastatin combination therapy significantly improves blood pressure and lipid control in high-risk, indigent African American patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Oliver et al. (2011) conducted an RCT in High-risk, resistant hypertension and dyslipidemia. Amlodipine/atorvastatin combination therapy with home BP monitoring vs. Usual care was evaluated on Reaching clinical BP and lipid goals (p=<.0001). Once-daily amlodipine/atorvastatin combination therapy with home BP monitoring achieved significant declines in BP, total cholesterol, and LDL in indigent African Americans.
Synapse has enriched 10 related papers. Consider them for comparative context: